Literature DB >> 19807377

Use of visual analog scales in economic evaluation.

John Brazier1, Colin Green, Christopher McCabe, Katherine Stevens.   

Abstract

Visual analog scales or rating scales are commonly used in economic evaluation to elicit preferences in order to estimate quality-adjusted life years. Values obtained from visual analog scales have been used on their own or via a transformation to map them onto one of the choice-based methods for elicting preferences, namely standard gamble or time trade-off. The arguments against using visual analog scales in economic evaluation directly or indirectly via a transformation are reviewed. It is concluded that it canonly ever provide a second best solution compared with the direct use of a choice-based technique.

Year:  2003        PMID: 19807377     DOI: 10.1586/14737167.3.3.293

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  13 in total

1.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

2.  A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms.

Authors:  Yvonne Anne Michel; Liv Ariane Augestad; Mathias Barra; Kim Rand
Journal:  Qual Life Res       Date:  2018-11-30       Impact factor: 4.147

3.  Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme.

Authors:  Janne A Martikainen; Akseli Kivioja; Taru Hallinen; Pia Vihinen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Patient and societal value functions for the testing morbidities index.

Authors:  J Shannon Swan; Chung Yin Kong; Janie M Lee; Omosalewa Itauma; Elkan F Halpern; Pablo A Lee; Sergey Vavinskiy; Olubunmi Williams; Emilie S Zoltick; Karen Donelan
Journal:  Med Decis Making       Date:  2013-05-20       Impact factor: 2.583

5.  The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale.

Authors:  Leida M Lamers; Carin A Uyl-de Groot; Ivonne Buijt
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.

Authors:  Dennis W Raisch; Patricia Feeney; David C Goff; K M Venkat Narayan; Patrick J O'Connor; Ping Zhang; Don G Hire; Mark D Sullivan
Journal:  Cardiovasc Diabetol       Date:  2012-07-11       Impact factor: 9.951

7.  A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus.

Authors:  Malin Ulfsdotter; Lene Lindberg; Anna Månsdotter
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

8.  A visual analog scale for patient-reported voice outcomes: The VAS voice.

Authors:  Matthew R Naunheim; Jennifer B Dai; Benjamin J Rubinstein; Leanne Goldberg; Alan Weinberg; Mark S Courey
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-12-17

9.  The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Health Qual Life Outcomes       Date:  2015-07-31       Impact factor: 3.186

10.  Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale.

Authors:  Edward J D Webb; John O'Dwyer; David Meads; Paul Kind; Penny Wright
Journal:  Eur J Health Econ       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.